ImmunologybioRxivPreprint
Targeting the chemokine receptor CXCR4 with histamine analogue to reduce inflammation in juvenile arthritis: a proof of concept for COVID-19 therapeutic approach
N. Bekaddour, N. Smith, B. Beitz…·J.-P. Herbeuval
This study shows that targeting CXCR4 with clobenpropit reduces inflammation in juvenile arthritis and COVID-19 by lowering cytokine levels and immune cell activity.
DOI 10.1101/2021.10.24.465080